
Meta-Analysis Highlights Cardiovascular Safety Advantage of Second-Generation BTK Inhibitors
<a href="https://news.google.com/rss/articles/CBMiyAFBVV95cUxQRnczMEFxTU9sMmZNNG9Ha3dMYXRlUm9GWUM1c2ViNWoxRzBDU1pGNDItQ0Q1TUFYdktOWXBxLUllYlZTcDl1VWRhX1hKX2c3SWRyaWxCNjA1S2VSMlN0NFJOSU82b1pWTktHbDJhOE1BTE1XYkNVTjdyUi1BdUUzUGVIRlNKS2IyVTJkVFVESThFSGJoVUdydlVFTXViLU92blIwYTViR2pxSDlNUzlfeks3LW42VHRYcFdwaXVDMWJHUm81WVN6Tg?oc=5" target="_blank">Meta-Analysis Highlights Cardiovascular Safety Advantage of Second-Generation BTK Inhibitors</a>&nbsp;&nbsp;<font color="#6f6f6f">The ASCO Post</font>
